Trend Revising? Biotech IPOs Slow Sharply In HK While Shanghai's STAR Shines

 
• By Brian Yang
  
Hong Kong
CHINESE BIOTECHS POSTPONE HONG KONG IPOS AMID LOW VALUATIONS, SHANGHAI COMPETITION • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business